Kathleen Bell , MD

Email: krbell@u.washington.edu

Phone: (206) 685-0935

Dr. Bell's area of interest and expertise has always been neuro-rehabilitation. Her clinical interests include traumatic brain injury (behavior management, headaches, sleep disorders, outcome), stroke, brain tumors and medically complex patients. Her research areas are: self management techniques for persons with brain injury, exercise and depression after brain injury, and headache and sleep disorders after brain injury.

View Bio

William Bensinger , MD

Email: wbensing@fredhutch.org

Phone: (206) 667-4933

Dr. Bensinger treats patients with multiple myeloma, amyloidosis, and plasmacytoma. His clinical interests are Autologous Stem Cell Transplantation, Immunotherapy and Targeted Radiotherapy.

View Bio

Shirley Beresford , PhD, MSc, MA

Email: beresfrd@u.washington.edu

Phone: (206) 543-9512

Dr. Beresford's research interests are in the areas of nutritional epidemiology and chronic disease prevention; specifically designed to improve the scientific basis for public health policy and recommendations concerning dietary intake, physical activity and intake of folic acid.

View Bio

Daniel Berg , MD

Email: danberg@uw.edu

Phone: (206) 598-6647

Dr. Berg's research interests include looking at skin cancer (diagnostics and treatment) in organ transplant patients and educational research including virtual reality simulation for dermatologic surgery; cutaneous laser surgery; cosmetic dermatologic surgery (including hair transplantation, tumescent liposuction).

View Bio

Alice Berger , PhD

Email: ahberger@fredhutch.org

Phone: (206) 667-6281

The goal of the Berger laboratory is to enable precision medicine by systematically uncovering the molecular alterations in cancer, determining the function of these variant alleles, and understanding how these alleles modulate response to targeted or immune-based therapies. Although many of the genes involved in cancer have now been identified, a major challenge is discovering which specific alleles of these genes are involved and how these alleles modulate therapeutic response. We combine functional genomics, computational biology, biochemistry, and genetics to understand the mechanism of somatic cancer variants. Our goal is to identify drug targets and biomarkers and to translate this knowledge into clinical benefit for patients.

View Bio

Irwin Bernstein , MD

Email: ibernste@fredhutch.org

Phone: (206) 667-1212

The research in Dr. Bernstein's lab has primarily focused on developmental aspects of hematopoiesis with the specific goal of developing novel therapeutic modalities.

View Bio

Slobodan Beronja , PhD

Email: beronja@fredhutch.org

Phone: (206) 667-7609

Dr. Beronja's group studies molecular and cellular mechanisms essential for tissue growth during development and the formation of tumors. His goal is to identifying genes and gene pathways that can be used as targets in cancer therapy.

View Bio

Parveen Bhatti , PhD

Email: pbhatti@fredhutch.org

Phone: (206) 667-7803

Dr. Bhatti's research focus is on occupational and environmental epidemiology of cancer with a focus in biomarkers of exposure, susceptibility and disease; particularly genetic susceptibility to cancer following low dose exposure to occupational or medical ionizing radiation.

View Bio

Amit Bhrany , MD

Email: abhrany@u.washington.edu

Phone: (206) 543-5230

Dr. Bhrany is a head and neck surgeon who focuses on facial cosmetic and reconstructive surgery, especially for cancer patients. Dr. Bhrany treats head and neck patients, including those with melanoma and non-melanoma skin cancers. A significant portion of his practice focuses on reconstruction of the face, head, and neck after cancer surgery.

View Bio

Jason Bielas , PhD

Email: jbielas@fredhutch.org

Dr. Bielas leads a group group studies the fundamental and clinical implications of nuclear and mitochondrial DNA mutations in the pathogenesis of cancer and age-related disease including breast and ovarian cancer. Recently, his laboratory has developed a new test for predicting ovarian cancer survival.

View Bio

Mark Binder , PhD

Email: mdbinder@uw.edu

Phone: (206) 543-2509

Dr. Binder's lab is presently investigating the dendritic mechanisms affecting the transfer of synaptic current to the soma of hypoglossal motoneurons recorded in rat brainstem slices. His team studies the voltage-dependance of the synaptic currents, what types of voltage-gated conductances on the dendrites affect the transfer of current to the soma and how concurrently-activated synaptic currents interact. They also use fluorescent imaging to determine the spatial distribution of the dendritic sodium, calcium, and mixed-cation channels. Binder's experimental projects are complemented by computer simulations using compartmental models of motoneurons with different types and distributions of dendritic conductances to help interpret the experimental data.

View Bio

C. Anthony (Tony) Blau , MD

Email: tblau@u.washington.edu

Phone: (206) 685-6873

Dr. Blau specializes in orchestrating collaborations across disparate scientific disciplines toward grand goals. As a physician-scientist he believes that our approach to cancer needs to be fundamentally restructured, and for this reason founded the UW's Center for Cancer Innovation (CCI). CCI applies the latest scientific knowledge to the treatment of today's cancer patients while using their experiences to benefit all cancer patients tomorrow. CCI recently launched its first clinical trial in an aggressive form of breast cancer called 'triple-negative' breast cancer. CCI is a grass-roots 'coalition of the willing,' comprised of nearly 100 community and academic oncologists, scientists, computational biologists, and other specialists from six different organizations, and owes much of its success to support from the South Sound region.

View Bio

Marie Bleakley , MD

Email: mbleakle@fredhutch.org

Phone: (206) 667-6572

Dr. Bleakley's research is focused on improving outcomes for patients with high-risk leukemia by developing new strategies that optimize the activities of T cells in the context of HCT. In particular, she is working to promote the advantageous Graft-Versus-Leukemia (GVL) effect and reduce the potentially dangerous GVHD that also can be caused by donor T cells after allogeneic transplantation.

View Bio

Jesse Bledsoe , PhD

Email: bledsoe1@washington.edu

Dr. Bledsoe studies brain-behavior relationships in pediatric brain tumors, neuroimaging, neuropsychology.

View Bio

Jesse Bloom , PhD

Email: jbloom@fredhutch.org

Phone: (206) 667-3622

Dr. Bloom studies the molecular evolution of proteins and viruses. Rapid evolution is a defining feature of many of the most medically problematic viral diseases, including influenza. Although this rapid evolution is usually bad from the perspective of public health, it offers a unique vantage from which to study a range of important questions in biology. His group takes an evolutionary perspective as we use a combination of experimental and computational techniques to study questions in virology, immunology, and protein biochemistry.

View Bio

Karl Bohringer , PhD

Email: karlb@u.washington.edu

Phone: (206) 221-5177

Dr. Bohringer's current research interests include micromanipulation and microassembly, as well as biomedical implants and bioMEMS for single-cell genomics and proteomics. There are two major research themes in his work: Controlling surfaces and interfacial forces at the micro and nano scale, including systems for controlled self-assembly of microcomponents, programmable surfaces whose local properties (for example, hydrophobicity) can be changed on demand, and MEMS actuator arrays and microrobots for moving tiny objects; Joining MEMS and biology by integrating new biomaterials into MEMS processes and devices, biomedical sensor implants, and microfluidic chips for handling and analyzing biological samples. Dr. Bohringer is also interested in discussing ideas for leveraging the unique capabilities of the Washington Nanofabrication Facility for research programs in the biomedical field.

View Bio

Hamid Bolouri , PhD

Email: hbolouri@fredhutch.org

Phone: (206) 667-2748

Dr. Bolouri is interested in understanding how gene regulatory interactions control cellular state and identity, both in normal development and in diseases such as cancer. A particular focus of his lab is the development and use of integrative computational systems biology methods to map gene regulatory networks from whole genome data: currently they are working on identification of cis-regulatory sequence variations in childhood Acute Myeloid Leukemia.

View Bio

Karol Bomsztyk , MD

Email: karolb@uw.edu

Phone: (206) 616-7949

Dr. Bomstyzk areas of research interest include pathogenesis of bacterial, fungal and parasitic diseases; epigenetics of inflammation and infection; and epigenetics of HIV infection.

View Bio